HIV prevention has developed significantly, giving people more choices based on their health needs, preferences and potential exposure to HIV. Pre exposure prophylaxis, commonly called PrEP, uses . . .
Modern HIV care continues to develop with medicines designed to address different treatment needs. Sunlenca contains lenacapavir, an antiviral medicine used with other antiretroviral medicines . . .
Sunlenca is a prescription medicine containing lenacapavir, an HIV 1 capsid inhibitor. It is used with other antiretroviral medicines for certain heavily treatment experienced adults whose multidrug . . .
Sunlenca, also known by its generic name lenacapavir, is an antiretroviral medicine used with other HIV medicines for certain adults with HIV 1 infection. The current United States prescribing . . .
Sunlenca, containing the active ingredient lenacapavir, is a long acting antiretroviral medicine used with other HIV medicines for certain adults whose HIV is multidrug resistant and whose . . .
Lenacapavir is an antiretroviral medicine belonging to the capsid inhibitor class. For HIV treatment, it is marketed as Sunlenca and is approved for certain adults with heavily treatment experienced, . . .
Sunlenca, the brand name for lenacapavir, is a long acting antiretroviral medicine used in specific HIV treatment situations. It belongs to a class called capsid inhibitors and . . .